Format

Send to

Choose Destination
Lancet Oncol. 2015 Aug;16(8):e370-1. doi: 10.1016/S1470-2045(15)00036-4.

Surgery versus SABR for resectable non-small-cell lung cancer.

Author information

1
The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia.
2
Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
3
Department of Surgery, Robert Wood Johnson Medical School, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
4
Department of Cardiothoracic Surgery, James Cook University Hospital, Middlesborough, UK.
5
Department of Thoracic Surgery, Institut Mutualiste Montsouris, Paris, France.
6
Department of Cardiothoracic Surgery, University Hospital of Copenhagen, Rigshospitalet, Copenhagen, Denmark.
7
Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
8
Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
9
Department of Surgery, University of Hong Kong, Hong Kong, China.
10
Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
11
Department of Cardiothoracic Surgery, Royal Infirmary of Edinburgh, Edinburgh, UK.
12
The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia; Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia. Electronic address: tristanyan@annalscts.com.
PMID:
26248836
DOI:
10.1016/S1470-2045(15)00036-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center